Join us on October 2, 2024, at 7 p.m. (EDT) for a practical lecture on recurrent feline urethral obstruction presented using clinical cases. This presentation will focus on the diagnostic, medical, and interventional strategies for managing a cat with post-urethral catheterization urinary blockage. In this webcast, Dr. Marilyn Dunn will cover practical tips, and cost-effective diagnostic methods that can be easily implemented in clinical practice. She will also review evidence-based treatment...

Join us on September 25 at 7 p.m. (EDT) as we discuss strategies to help veterinary teams manage this condition effectively. Fibrosarcomas are relatively common in cats. It is of utmost importance to differentiate vaccine or injection site-associated sarcoma (VAS) from non-vaccine-associated sarcoma as the prognosis and treatment strategies for each type differ significantly. In this webcast, Dr. Philip J. Bergman will focus on the history, possible impact from adjuvant vs. not, diagnosis,...

Join us on September 19 at 7 p.m. (EDT) as we explore strategies to help veterinary teams stay ahead of emerging challenges in dermatology cases. Discover the latest advancements in managing bacterial resistance in veterinary care. In this webcast, Dr. Anthony Yu will review the mechanisms and concerns regarding the emergence of Methicillin-resistant Staphylococcus biocide resistance to some of our trusted topical therapies such as chlorhexidine, mupirocin, and fucidin. He will also examine...

Antimicrobial resistance is increasingly recognized as a significant global threat to public health. Prudent use of antibiotics is an integral part of best veterinary practices. During this webcast, Dr. Vincent Defalque will focus on canine superficial pyoderma, the most prevalent infection in veterinary dermatology. The discussion will include evidence-based recommendations for diagnosing and treating methicillin-resistant staphylococcal skin infections. This webcast is presented in...

Watch this webcast to learn about the ins and outs of rabies and how to prevent this disease! It’s fair to say that veterinarians are among the health care providers who have an excellent understanding of the risks associated with rabies virus: all mammals (including humans) are susceptible; infected dogs and cats pose a high risk for transmission to humans; infection is virtually fatal; rabies vaccination of dogs and cats is an exceptionally safe and effective public health measure, etc....

Challenges related to pet-owner costs and other barriers to animal care have always been a part of veterinary practice. However, these day-to-day difficulties appear to be increasing, with growing attention to the ‘access to care’ veterinary crisis impacting our patients, clients, and veterinary care teams. One proposed solution to this problem is the deliberate incorporation of Spectrum of Care into practice (i.e., evidence-based care options along the continuum of acceptable care). During...

Dermatopicals are often underutilized in managing veterinary dermatology patients. However, they can be an essential part of a multimodal treatment plan, aiding in the repair of the skin barrier, which is so often disrupted in patients with skin disease. During this webcast, learn from veterinary dermatologist, Dr. Charlie Pye, as she discusses:barrier dysfunction in allergic patients;some of the barriers to implementing topical therapy;the benefits of topical therapy for dermatology patients.

Empowering technicians in OA treatment!This webcast is presented as part of our series on canine osteoarthritis addressing pathogenesis, disease awareness, canine and owner quality of life, and osteoarthritis management, including new developments. In this webcast, Dr. Georgina Beaumont and Evie Tummon, RVT, provide comprehensive up-to-date education on various aspects of canine osteoarthritis (OA) from a new perspective, the RVT's perspective, and the important role RVTs/AHT play in...

Monoclonal antibodies have emerged in the management of dogs and cats suffering from osteoarthritis. After three years in European markets, what have we learned about this new type of treatment? What is the real place of this therapy in the management of osteoarthritis? During this webcast, Dr. Guillaume Ragetly, French specialist in surgery, will share with you his clinical approach based on clinical studies and cases, in addition to answering your most frequently asked questions.